247 related articles for article (PubMed ID: 17727214)
21. Squamous cell carcinoma of the esophagus: multimodal therapy in locally advanced disease.
El Nakadi I; Van Laethem JL; Houben JJ; Gay F; Closset J; Van Houtte P; Danhier S; Limbosch JM; Lambilliotte JP; Gelin M
World J Surg; 2002 Jan; 26(1):72-8. PubMed ID: 11898037
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant therapy for esophageal cancer: standard of care or elusive myth?
Boyle MJ; Franceschi D; Robinson DS; Livingstone AS
Am Surg; 2001 Oct; 67(10):956-65. PubMed ID: 11603553
[TBL] [Abstract][Full Text] [Related]
23. Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation.
Klevebro F; Johnsen G; Johnson E; Viste A; Myrnäs T; Szabo E; Jacobsen AB; Friesland S; Tsai JA; Persson S; Lindblad M; Lundell L; Nilsson M
Eur J Surg Oncol; 2015 Jul; 41(7):920-6. PubMed ID: 25908010
[TBL] [Abstract][Full Text] [Related]
24. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
25. Chemo-radiotherapy in locally advanced squamous cell oesophageal cancer--are upper third tumours more responsive?
Papp A; Cseke L; Farkas R; Pavlovics G; Horvath G; Varga G; Szigeti A; Bellyei S; Marton S; Poto L; Kalmar K; Vereczkei A; Pozsgai E; Horvath OP
Pathol Oncol Res; 2010 Jun; 16(2):193-200. PubMed ID: 19760123
[TBL] [Abstract][Full Text] [Related]
26. Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity.
Rice DC; Correa AM; Vaporciyan AA; Sodhi N; Smythe WR; Swisher SG; Walsh GL; Putnam JB; Komaki R; Ajani JA; Roth JA
Ann Thorac Surg; 2005 Feb; 79(2):391-7; discussionn 391-7. PubMed ID: 15680801
[TBL] [Abstract][Full Text] [Related]
27. Combined chemotherapy and radiotherapy followed by surgery in the treatment of patients with squamous cell carcinoma of the esophagus.
Adham M; Baulieux J; Mornex F; de La Roche de Bransat E; Ducerf C; Souquet JC; Gerard JP
Cancer; 2000 Sep; 89(5):946-54. PubMed ID: 10964323
[TBL] [Abstract][Full Text] [Related]
28. [Squamous cell carcinoma of the oesophagus--impact of surgery within the therapeutic concept].
Gockel I; Lang H
Z Gastroenterol; 2010 May; 48(5):560-6. PubMed ID: 20449788
[TBL] [Abstract][Full Text] [Related]
29. [New trends in neoadjuvant chemoradiotherapy for locally-advanced esophageal cancer: esophagectomy--is it necessary?].
Fujita H; Sueyoshi S; Tanaka T; Toh U; Mine T; Sasahara H; Shirouzu K; Yamana H; Toda Y; Hayabuchi N
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2016-22. PubMed ID: 11103231
[TBL] [Abstract][Full Text] [Related]
30. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
[TBL] [Abstract][Full Text] [Related]
31. Induction chemotherapy followed by surgery for advanced oesophageal cancer.
Toxopeus EL; Talman S; van der Gaast A; Spaander VM; van Rij CM; Krak NC; Biermann K; Tilanus HW; Mathijssen RH; van Lanschot JJ; Wijnhoven BP
Eur J Surg Oncol; 2015 Mar; 41(3):323-32. PubMed ID: 25534280
[TBL] [Abstract][Full Text] [Related]
32. Outcomes after trimodality therapy for esophageal cancer: the impact of histology on failure patterns.
Koshy M; Greenwald BD; Hausner P; Krasna MJ; Horiba N; Battafarano RJ; Burrows W; Suntharalingam M
Am J Clin Oncol; 2011 Jun; 34(3):259-64. PubMed ID: 20686405
[TBL] [Abstract][Full Text] [Related]
33. [Neoadjuvant treatment in surgery of esophageal cancer].
Launois B; Raoul JL; Leprise E; Meunier B
Bull Acad Natl Med; 2000; 184(8):1703-13; discussion 1714. PubMed ID: 11471389
[TBL] [Abstract][Full Text] [Related]
34. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
Elsaleh H; Farrell JJ; Crane CH
J Gastroenterol Hepatol; 2009 May; 24(5):708-10. PubMed ID: 19646012
[No Abstract] [Full Text] [Related]
35. Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients.
Hoeppner J; Zirlik K; Brunner T; Bronsert P; Kulemann B; Sick O; Marjanovic G; Hopt UT; Makowiec F
J Surg Oncol; 2014 Mar; 109(3):287-93. PubMed ID: 24277235
[TBL] [Abstract][Full Text] [Related]
36. [Neoadjuvant therapy in oesophageal cancer surgery].
Imdahl A
Zentralbl Chir; 2006 Apr; 131(2):105-9. PubMed ID: 16612775
[TBL] [Abstract][Full Text] [Related]
37. [Principles of treatment in locally advanced esophageal squamous cancer].
Constantinoiu S; Hanna A; Bîrlă R; Anghel R; Tavlas E; Mocanu A; Hoară P
Chirurgia (Bucur); 2010; 105(1):7-14. PubMed ID: 20405674
[TBL] [Abstract][Full Text] [Related]
38. Interval between neoadjuvant chemoradiotherapy and surgery for squamous cell carcinoma of the thoracic esophagus: does delayed surgery have an impact on outcome?
Ruol A; Rizzetto C; Castoro C; Cagol M; Alfieri R; Zanchettin G; Cavallin F; Michieletto S; Da Dalt G; Sileni VC; Corti L; Mantoan S; Zaninotto G; Ancona E
Ann Surg; 2010 Nov; 252(5):788-96. PubMed ID: 21037434
[TBL] [Abstract][Full Text] [Related]
39. Induction chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus: impact of increased dosage on long-term results.
de Manzoni G; Pedrazzani C; Laterza E; Pasini F; Grandinetti A; Bernini M; Ruzzenente A; Zerman G; Tomezzoli A; Cordiano C
Ann Thorac Surg; 2005 Oct; 80(4):1176-83. PubMed ID: 16181836
[TBL] [Abstract][Full Text] [Related]
40. Clinical response to induction chemotherapy predicts local control and long-term survival in multimodal treatment of patients with locally advanced esophageal cancer.
Stahl M; Wilke H; Stuschke M; Walz MK; Fink U; Molls M; Siewert JR; Schroeder M; Makoski HB; Schmidt U; Seeber S; Vanhoefer U
J Cancer Res Clin Oncol; 2005 Jan; 131(1):67-72. PubMed ID: 15480782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
